Difference between revisions of "Part:BBa K914009:Experience"
(→Applications of BBa_K914009) |
(→Applications of BBa_K914009) |
||
Line 10: | Line 10: | ||
[[Image:SCquantitativeF2.png|thumb|center|800px|'''Figure 4C:''' The variations of the OD<sub>600</sub> is observed in function of the time, for different concentrations of kanamycin (400µg/mL, 100µg/mL, 25µg/mL).]] | [[Image:SCquantitativeF2.png|thumb|center|800px|'''Figure 4C:''' The variations of the OD<sub>600</sub> is observed in function of the time, for different concentrations of kanamycin (400µg/mL, 100µg/mL, 25µg/mL).]] | ||
+ | |||
+ | |||
+ | This part has been further characterised by Edinburgh UG 2018: | ||
+ | |||
+ | http://2018.igem.org/Team:Edinburgh_UG/Results | ||
===User Reviews=== | ===User Reviews=== |
Revision as of 02:29, 18 October 2018
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K914009
The leakiness of the Kan* gene is higher than expected, and thus one mutation is not sufficient for the containment. Indeed, at usual concentration, Kan* gene manages to express an antibiotic resistance, even though lower than KanR or supD (Figure 4A). Here we define the growth rate as the OD600 observed at a given time (here t=8h20'), in order to overcome the fact that Kan*+RFP does not have a clear exponential phase. The fact that the strain (3) grows faster and can have higher OD600 may be explain by the fact that supD is deleterious for the strain, by removing some stop codon of other genes for instance.
This part has been further characterised by Edinburgh UG 2018:
http://2018.igem.org/Team:Edinburgh_UG/Results
User Reviews
UNIQ73b105d628b85916-partinfo-00000000-QINU UNIQ73b105d628b85916-partinfo-00000001-QINU